All News

"As evidenced by the flurry of activity at the state and federal levels of government, many physicians are fighting back against increasingly burdensome recertification requirements," writes the AACU's Ross E. Weber.

As a result of strong opposition from organized medicine, including the AUA and patients, the Centers for Medicare & Medicaid Services has put on hold its development of a draft plan to penalize physicians for ordering “non-recommended” PSA tests to screen for prostate cancer.

The next few years may bring more change for urologists in a more compressed time frame than ever before. Could a perfect storm be brewing, and what should you be doing about it?

In men with metastatic prostate cancer, those assigned to intermittent androgen deprivation therapy have more ischemic and thrombotic events than those assigned to continuous androgen deprivation, according to Columbia University researchers.

If medical specialties were competing for which would have the most dire shortage of practicing physicians by 2025, urologists would likely win.

Treatment options for high-risk prostate cancer perform similarly. In a single-institution study, radical prostatectomy was associated with worse biochemical failure, less clinical failure, and superior prostate cancer-specific mortality compared with radiation therapy and brachytherapy, reported Jay P. Ciezki, MD, at the 2016 Genitourinary Cancers Symposium in San Francisco.

Gynecologists derive higher complication rates than urologists during the first 30 days following sling procedures for urinary incontinence, according to a multicenter study presented at the European Association of Urology annual congress in Munich, Germany.

"I have no personal experience with marijuana. But I do practice medicine in Colorado and given the state’s ongoing experiment with legal recreational marijuana, I am accumulating a significant amount of professional experience with the drug," writes Henry Rosevear, MD.

Four current clinical practice guidelines on prostate cancer provide urologists with valuable, evidence-based decision points about diagnosis and treatment while raising questions that will likely be addressed by future research.